cgs 20625 has been researched along with flunitrazepam in 1 studies
| Studies (cgs 20625) | Trials (cgs 20625) | Recent Studies (post-2010) (cgs 20625) | Studies (flunitrazepam) | Trials (flunitrazepam) | Recent Studies (post-2010) (flunitrazepam) |
|---|---|---|---|---|---|
| 9 | 0 | 2 | 2,697 | 298 | 130 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, DA; Braunwalder, AF; Jarvis, MF; Loo, PA; Schmutz, M; Thompson, TN; Wasley, JW; Williams, M; Yokoyoma, N | 1 |
1 other study(ies) available for cgs 20625 and flunitrazepam
| Article | Year |
|---|---|
CGS 20625, a novel pyrazolopyridine with selective anxiolytic activity.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Biological Availability; Diazepam; Flunitrazepam; Learning; Male; Motor Activity; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter | 1990 |